Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2071703
Abstract: ABSTRACT Introduction Neuroendocrine carcinomas are very aggressive tumors with few treatment options. DLL3 seems to be an optimal target for therapeutic intervention, as it is expressed mainly on the membrane of tumor cells with neuroendocrine… read more here.
Keywords: neuroendocrine origin; ligand dll3; target; like ligand ... See more keywords